These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
391 related articles for article (PubMed ID: 20028429)
1. Dissociated expression of natural killer 1.1 and T-cell receptor by invariant natural killer T cells after interleukin-12 receptor and T-cell receptor signalling. Emoto M; Shimizu T; Koike H; Yoshizawa I; Hurwitz R; Kaufmann SH; Emoto Y Immunology; 2010 Jan; 129(1):62-74. PubMed ID: 20028429 [TBL] [Abstract][Full Text] [Related]
2. Reversible NK1.1 surface expression on invariant liver natural killer T cells during Listeria monocytogenes infection. Emoto M; Yoshizawa I; Emoto Y; Takahashi Y; Hurwitz R; Miamoto M; Kaufmann SH Microbes Infect; 2007; 9(14-15):1511-20. PubMed ID: 18024119 [TBL] [Abstract][Full Text] [Related]
3. Miscarriage induced by adoptive transfer of dendritic cells and invariant natural killer T cells into mice. Negishi Y; Ichikawa T; Takeshita T; Takahashi H Eur J Immunol; 2018 Jun; 48(6):937-949. PubMed ID: 29520760 [TBL] [Abstract][Full Text] [Related]
4. Enhancement of the synthetic ligand-mediated function of liver NK1.1Ag+ T cells in mice by interleukin-12 pretreatment. Habu Y; Uchida T; Inui T; Nakashima H; Fukasawa M; Seki S Immunology; 2004 Sep; 113(1):35-43. PubMed ID: 15312134 [TBL] [Abstract][Full Text] [Related]
5. Role of interleukin-12 in determining differential kinetics of invariant natural killer T cells in response to differential burden of Listeria monocytogenes. Emoto Y; Yoshizawa I; Hurwitz R; Brinkmann V; Kaufmann SH; Emoto M Microbes Infect; 2008 Mar; 10(3):224-32. PubMed ID: 18321748 [TBL] [Abstract][Full Text] [Related]
6. Activation of human invariant natural killer T cells with a thioglycoside analogue of α-galactosylceramide. Hogan AE; O'Reilly V; Dunne MR; Dere RT; Zeng SG; O'Brien C; Amu S; Fallon PG; Exley MA; O'Farrelly C; Zhu X; Doherty DG Clin Immunol; 2011 Aug; 140(2):196-207. PubMed ID: 21493160 [TBL] [Abstract][Full Text] [Related]
7. The complementarity determining region 2 of BV8S2 (V beta 8.2) contributes to antigen recognition by rat invariant NKT cell TCR. Pyz E; Naidenko O; Miyake S; Yamamura T; Berberich I; Cardell S; Kronenberg M; Herrmann T J Immunol; 2006 Jun; 176(12):7447-55. PubMed ID: 16751390 [TBL] [Abstract][Full Text] [Related]
8. Production of both IL-27 and IFN-gamma after the treatment with a ligand for invariant NK T cells is responsible for the suppression of Th2 response and allergic inflammation in a mouse experimental asthma model. Fujita H; Teng A; Nozawa R; Takamoto-Matsui Y; Katagiri-Matsumura H; Ikezawa Z; Ishii Y J Immunol; 2009 Jul; 183(1):254-60. PubMed ID: 19542437 [TBL] [Abstract][Full Text] [Related]
9. Natural Killer T-Cell Agonist α-Galactosylceramide and PD-1 Blockade Synergize to Reduce Tumor Development in a Preclinical Model of Colon Cancer. Wang Y; Bhave MS; Yagita H; Cardell SL Front Immunol; 2020; 11():581301. PubMed ID: 33193386 [TBL] [Abstract][Full Text] [Related]
10. α-galactosylceramide generates lung regulatory T cells through the activated natural killer T cells in mice. Chen Q; Guo X; Deng N; Liu L; Chen S; Wang A; Li R; Huang Y; Ding X; Yu H; Hu S; Nie H J Cell Mol Med; 2019 Feb; 23(2):1072-1085. PubMed ID: 30421497 [TBL] [Abstract][Full Text] [Related]
11. CpG oligonucleotide-mediated co-stimulation of mouse invariant natural killer T cells negatively regulates their activation status. Kulkarni RR; Villanueva AI; Read LR; Brisbin JT; Bhaumik SK; LaMarre J; Murali-Krishna K; Sharif S Cell Tissue Res; 2017 Sep; 369(3):541-554. PubMed ID: 28550425 [TBL] [Abstract][Full Text] [Related]
12. Identification of an IL-17-producing NK1.1(neg) iNKT cell population involved in airway neutrophilia. Michel ML; Keller AC; Paget C; Fujio M; Trottein F; Savage PB; Wong CH; Schneider E; Dy M; Leite-de-Moraes MC J Exp Med; 2007 May; 204(5):995-1001. PubMed ID: 17470641 [TBL] [Abstract][Full Text] [Related]
13. Expansion of invariant natural killer T cells from systemic lupus erythematosus patients by alpha-Galactosylceramide and IL-15. Hsu CY; Chueh YS; Kuo ML; Lee PT; Hsiao HS; Huang JL; Lin SJ PLoS One; 2021; 16(12):e0261727. PubMed ID: 34936686 [TBL] [Abstract][Full Text] [Related]
14. Activation of invariant natural killer T cells by α-galactosylceramide ameliorates myocardial ischemia/reperfusion injury in mice. Homma T; Kinugawa S; Takahashi M; Sobirin MA; Saito A; Fukushima A; Suga T; Takada S; Kadoguchi T; Masaki Y; Furihata T; Taniguchi M; Nakayama T; Ishimori N; Iwabuchi K; Tsutsui H J Mol Cell Cardiol; 2013 Sep; 62():179-88. PubMed ID: 23774048 [TBL] [Abstract][Full Text] [Related]
15. α-Galactosylceramide-activated murine NK1.1(+) invariant-NKT cells in the myometrium induce miscarriages in mice. Ichikawa T; Negishi Y; Shimizu M; Takeshita T; Takahashi H Eur J Immunol; 2016 Aug; 46(8):1867-77. PubMed ID: 27198610 [TBL] [Abstract][Full Text] [Related]
16. Negative modulation of invariant natural killer T cell responses to glycolipid antigens by p38 MAP kinase. Stuart JK; Bisch SP; Leon-Ponte M; Hayatsu J; Mazzuca DM; Maleki Vareki S; Haeryfar SM Int Immunopharmacol; 2010 Sep; 10(9):1068-76. PubMed ID: 20584631 [TBL] [Abstract][Full Text] [Related]
17. Human invariant V alpha 24-J alpha Q TCR supports the development of CD1d-dependent NK1.1+ and NK1.1- T cells in transgenic mice. Capone M; Cantarella D; Schümann J; Naidenko OV; Garavaglia C; Beermann F; Kronenberg M; Dellabona P; MacDonald HR; Casorati G J Immunol; 2003 Mar; 170(5):2390-8. PubMed ID: 12594262 [TBL] [Abstract][Full Text] [Related]
18. Invariant NKT cell anergy is induced by a strong TCR-mediated signal plus co-stimulation. Iyoda T; Ushida M; Kimura Y; Minamino K; Hayuka A; Yokohata S; Ehara H; Inaba K Int Immunol; 2010 Nov; 22(11):905-13. PubMed ID: 21118907 [TBL] [Abstract][Full Text] [Related]